All View

Product Information BR-1270_PI_01.pdf
Registration Number BR-1270
Generic Name Insulin Glargine/ Lixisenatide
Brand Name Soliqua
Dosage Strength 3.64 mg (equivalent to 100 Units of Insulin glargine) / 50 mcg per mL
Dosage Form Solution for Injection (SC)
Classification Prescription (Rx) Drug
Packaging 3 mL-net content Type I glass cartridge with black bromobutyl rubber plunger stopper, aluminum flanged cap with punched laminated sealing disk assembled into a disposable pen-injector made of polypropylene (Box of 1's, 3's and 5's).
Pharmacologic Category Long-acting Insulin and Analogue.
Manufacturer Sanofi-Aventis Deutschland GmbH
Country of Origin Germany
Importer Sanofi-Aventis Philippines, Inc.
Distributor Sanofi-Aventis Philippines, Inc.
Application Type Initial (from Monitored Release)
Issuance Date 06 March 2024
Expiry Date 09 May 2028